Clinical Trials Directory

Trials / Conditions / Ovarian Brenner Tumor

Ovarian Brenner Tumor

16 registered clinical trials studyying Ovarian Brenner Tumor.

StatusTrialSponsorPhase
Active Not RecruitingGemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian,
NCT02101775
National Cancer Institute (NCI)Phase 2
WithdrawnAcetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithe
NCT01492920
Gynecologic Oncology GroupPhase 3
TerminatedGranisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherap
NCT01275664
Gynecologic Oncology GroupN/A
CompletedTLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients Wit
NCT01294293
Gynecologic Oncology GroupPhase 1
CompletedElesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer,
NCT00888615
GOG FoundationPhase 2
Active Not RecruitingPaclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage
NCT01167712
National Cancer Institute (NCI)Phase 3
CompletedIntraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelia
NCT01074411
National Cancer Institute (NCI)Phase 1
CompletedChanges in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone
NCT01080521
Gynecologic Oncology Group—
CompletedCarboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovar
NCT00989651
National Cancer Institute (NCI)Phase 1
CompletedA6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim
NCT00939809
Gynecologic Oncology GroupPhase 2
CompletedCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithe
NCT00814086
Gynecologic Oncology GroupPhase 1
Active Not RecruitingCarboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Pa
NCT00565851
National Cancer Institute (NCI)Phase 3
CompletedCarboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian
NCT00262847
National Cancer Institute (NCI)Phase 3
UnknownPaclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian E
NCT00108745
GOG FoundationPhase 3
CompletedPolyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopia
NCT00060359
Gynecologic Oncology GroupPhase 1
CompletedCollecting Tumor Samples From Patients With Gynecological Tumors
NCT00897442
Gynecologic Oncology Group—